Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Clinical trial NCT00123760 · COMPLETED

Trial details

NCT number: NCT00123760
Sponsor: AHS Cancer Control Alberta
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Brain Neoplasms Lung Neoplasms Thyroid Neoplasms Colorectal Neoplasms Lymphoma

Start date: 2004-02-01
Primary completion: 2008-12-01
Enrollment: 10838

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.